• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:齐蕴文,郭良清,韩晓春.基于转录组学探讨七味白术散对2型糖尿病大鼠肠道神经元胞体mRNA的影响[J].药学研究,2025,44(9):859-863,881[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1946次   下载 719次 本文二维码信息
码上扫一扫!
基于转录组学探讨七味白术散对2型糖尿病大鼠肠道神经元胞体mRNA的影响
齐蕴文1,郭良清2,韩晓春1
字体:加大+|默认|缩小-
(1.山东中医药大学,山东 济南 250355;2.山东中医药大学附属医院,山东 济南 250012)
摘要:
目的 以2型糖尿病大鼠模型为研究对象,基于高通量转录组测序探讨七味白术散对模型动物肠道神经元胞体mRNA的影响。方法 采用注射链脲佐菌素(Streptozocin,STZ)联合高脂高糖饮食法构建2型糖尿病大鼠模型,将大鼠分为对照组、模型组和七味白术散治疗组,每组随机抽取3只大鼠进行肠道mRNA 测序。对模型组和对照组进行基因本体(gene ontology,GO)富集分析,根据细胞组件中的神经元胞体功能进行差异基因的确定,将注释到的3组差异基因以IBM SPSS Statistics 25软件包进行主成分分析(principal component analysis,PCA)及聚类分析,并对主成分分析的载荷和得分进行Bi分析。结果 模型大鼠与对照大鼠神经元胞体功能差异基因为13条; 对差异基因主成分分析的载荷和得分进行Bi分析显示模型组与对照组区分明显,与样本聚类结果一致;对PC1、PC2和PC3进行归一化发现,各基因权重不同,权重在前10位的为: Plxdc1、Sez6l、Adora1、Trpm5、Trpm2、Ncf1、Lrrk2、Cd40、Klhl14、Cdk5r1,为七味白术散通过肠道神经元胞体治疗2型糖尿病大鼠的关键靶点。结论 七味白术散能够改善造模刺激导致的肠道神经元胞体损伤,可通过上调Plxdc1、Sez6l、Adora1、Trpm5、Trpm2等基因的mRNA表达水平维持肠道神经元胞体的正常功能,从而调节葡萄糖代谢平衡维持肠道稳态,有效控制2型糖尿病进展。
关键词:  七味白术散  2型糖尿病  转录组学  肠道神经元胞体  mRNA
DOI:10.13506/j.cnki.jpr.2025.09.004
基金项目:山东省自然科学基金项目(No.ZR2022MH054、ZR2019MH064);山东省重点研发计划项目(No.2019GSF108210);2022年中医药古籍文献和特色技术传承项目(No.0686-2211CA080200Z);山东省老年医学学会项目(No.LKJGG2021W110);山东省中医药科技项目(No.2021Z044)
出版日期:2025-09-25
The effects of Qiwei Baizhu San on the mRNA expression of enteric neuron cell bodies in type 2 diabetic rats based on transcriptomics
QI Yunwen1,GUO Liangqing2,HAN Xiaochun1
(1. Shandong University of Traditional Chinese Medicine, Jinan 250355,China; 2. Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250012,China)
Abstract:
Objective To investigate the effect of Qiwei Baizhu San on the mRNA of enteric neuron cell bodies in type 2 diabetes rat model based on high-throughput transcriptome sequencing. Methods The type 2 diabetes rat model was established by injection of Streptozocin (STZ) combined with high-fat and high-sugar diet, and the rats were divided into control group, model group and Qiwei Baizhu San treatment group. 3 rats in each group were randomly selected for intestinal mRNA sequencing.Gene Ontology (GO) enrichment analysis was performed on the model and control groups. Differentially expressed genes were identified based on the function of neuron cell bodies in the cellular component. The annotated 3 groups of differentially expressed genes were analyzed using IBM SPSS Statistics 25 software for Principal Component Analysis (PCA) and clustering analysis, and Bi analysis was conducted on the loadings and scores of the principal component analysis. Results There were 13 differentially expressed genes in the function of neuron cell bodies between the model rats and the control rats. The Bi analysis of the loadings and scores of the principal component analysis of the differentially expressed genes showed a clear distinction between the model group and the control group, consistent with the results of the sample clustering. After normalization of PC1, PC2, and PC3, it was found that the weights of the genes were different, and the top 10 genes by weight were Plxdc1, Sez6l, Adora1, Trpm5, Trpm2, Ncf1, Lrrk2, Cd40, Klhl14, and Cdk5r1. These genes were identified as key targets for the treatment of type 2 diabetes in rats by Qiwei Baizhu San via enteric neuron cell bodies. Conclusion Qiwei Baizhu San can ameliorate the damage of enteric neuron cell bodies induced by modeling stimulation, and maintain the normal function of enteric neuron cell bodies by up-regulating the mRNA expression levels of Plxdc1, Sez6l, Adora1, Trpm5, Trpm2, Ncf1, Lrrk2, Cd40, Klhl14, and Cdk5r1. It can regulate the balance of glucose metabolism to maintain the enteric homeostasis and effectively control the progression of type 2 diabetes mellitus.
Key words:  Qiwei Baizhu San  Type 2 diabetes mellitus  Transcriptomics  Enteric neuron cell bodies  mRNA
今日访问量:2470    总访问量:55338900
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司